NCT05384522View on ClinicalTrials.gov

Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease

Not yet recruitingOBSERVATIONAL

Enrollment

103

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

January 30, 2026

Study Completion Date

January 30, 2026

Conditions

Parkinson Disease

Interventions

OTHER

blood samples collection

Blood samples will be drawn at baseline and at 6 and 12 months from baseline

All Listed Sponsors

lead

Istituto Nazionale di Ricovero e Cura per Anziani

OTHER

NCT05384522 - Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease | Biotech Hunter | Biotech Hunter